PRME
Prime Medicine, Inc. Common Stock
NASDAQ: PRME · HEALTHCARE · BIOTECHNOLOGY
$3.53
-4.34% today
Updated 2026-04-29
Market cap
$666.47M
P/E ratio
—
P/S ratio
143.88x
EPS (TTM)
$-1.35
Dividend yield
—
52W range
$1 – $7
Volume
2.5M
Prime Medicine, Inc. Common Stock (PRME) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-1.33M | $-5.54M | $-34.08M | $-131.83M | $-165.41M | $-122.86M | $-162.56M |
| Capital expenditures | $639000.00 | $639000.00 | $4.15M | $16.09M | $8.72M | $7.29M | $4.53M |
| Depreciation | — | — | — | — | — | — | — |
| Stock-based comp | — | $391000.00 | $1.75M | $6.46M | $13.91M | $26.07M | $29.27M |
| Free cash flow | $-1.97M | $-6.18M | $-38.23M | $-147.92M | $-174.14M | $-130.16M | $-167.09M |
| Investing cash flow | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $2.57M | — | — | — |